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ABSTRACT 
Objective: The study aimed to investigate the antidiabetic effect of ethyl acetate fraction of seed of Eugenia jambolana (E. jambolana) at genomic 
level in streptozotocin (STZ) induced diabetic male albino rat. 
Methods: Diabetic rats were treated with said fraction at the dose of 200 mg/Kg of body weight/day for 35 days. Potential antidiabetic mechanisms 
were investigated with blood glucose (short duration and long duration model), serum insulin, haemoglobin A1C (HbA1
Results: Results showed a significant antihyperglycemic action of the said fraction in both short and long duration treatment schedule. Serum 
insulin and HbA
C), ISEL (In-Situ End 
Labelling) study of pancreatic tissue and quantitative RT-PCR study of hepatic hexokinase-I (Hex-I), Bax and Bcl-2 gene expression. 
1
Conclusion: The findings provide information about the antihyperglycemic activity of this fraction through gene regulation. 
C levels were also recovered in treated group in compare to the untreated diabetic group (p<0.05). ISEL study focused the 
regeneration of pancreatic beta cells in treated group. It was also observed that the correction in expression in Bax, Bcl-2 and Hex-I gene in hepatic tissue 
after the treatment of the fraction in the diabetic rat. The antidiabetic activity of the fraction was compared with glibenclamide, a standard antidiabetic drug.  
Keywords: Bax, Bcl-2, Diabetes, E. jambolana, Hexokinase-I. 
 
INTRODUCTION 
It is known that diabetes is possibly the world’s fastest growing 
metabolic disease [1]. Chronic hyperglycemia is the most well-
known symptoms of Non-Insulin Dependent Diabetes Mellitus 
(NIDDM), which is important for development of diabetic 
complications [2]. There are several reasons for enhancement of 
blood glucose level in diabetic people. Refuse in insulin secretion, 
defect in glucose transport system (GLUT1, GLUT4) [3], and 
improvement of hydrolytic activity of intestinal brush border 
membrane are three important causes of hyperglycemia in diabetic 
people [4]. Several synthetic drugs are used for the treatment of 
diabetes but no one is without side effects and hence there is need 
for alternative improvement of oral hypoglycemic agents [5-6]. 
Hypoglycemic effects of different herbal plants are recognized to 
their ability to restore the function of pancreatic β cell by causing an 
increase in insulin secretion or slow down the intestinal absorption 
of glucose [7-8]. Many herbal plant species having 
antihyperglycemic activity are available in worldwide [9]. Most of 
the plants contain terpenoids, flavonoids, carotenoids, glycosides, 
alkaloids, those are frequently used as antidiabetic agents [10].  
E. jambolana has been widely used in Indian traditional medicine for 
remedy of various ailments. Different parts of E. jambolana such as 
kernel, leaves and septum have a significant antihyperglycemic 
effect. Antihyperglycemic activity of ethyl acetate fraction of seed of 
E. jambolana has been reported previously by us [11-14], but its 
molecular mechanism for antidiabetic activity has not yet been 
described clearly. Hence, the present study was conducted to 
explore the molecular mechanism of action of ethyl acetate fraction 
of seeds of E. jambolana in STZ-induced diabetes rat.  
MATERIALS AND METHODS 
Bioactivity-guided ethyl acetate fractionation of hydro 
methanolic (2:3) extract of seed of E. jambolana. 
For preparation of ethyl acetate fraction, the seeds of E. jambolana 
were collected in rainy season (July–August) from the local market 
at Midnapore town, West Bengal, India. The specimen were 
authenticated by the taxonomist in the Dept. of Botany and Forestry, 
Vidyasagar University, Midnapore, where the voucher specimen was 
preserved having Ref. No.- BMLSM-10/06. The preparation of crude 
extract using hydro-methanol (2:3) as solvent mixture followed by 
its fractionation using ethyl acetate was performed according to our 
previously reported method [12].  
Selection of animal and animal care  
The matured normoglycemic wistar strain male albino rats, having 
three months of age, weighing about 120 ± 10 g and fasting blood 
glucose (FBG) levels were 80-90 mg/dl, were used for this 
experiment. Rats were housed at an ambient temperature of 25 ± 
20
Induction of diabetes mellitus 
C with 12 h light: 12 h dark cycle. Rats were provided with protein 
rich standard feed and water ad libitum. The principle of animal care 
and directions was maintained throughout the experiment which 
has been given by our Institutional Ethical Committee (IEC) which is 
in conformity with the guidelines of the Committee for the Purpose 
of Control and Supervision of Experimental Animals (CPCSEA). 
Rats were made diabetic by a single intramuscular injection of STZ 
(Sigma Aldrich, USA) at a dose of 40 mg/kg of body weight. STZ was 
dissolved in 0.1M citrate buffer (pH 4.5). After 7 days of injection, 
diabetes was confirmed by determining the FBG level. The rats with 
FBG levels of 300-350 mg/dl were only considered for the 
experiment [15].  
Design 
The rats were divided into four groups having six animals in each group. 
Control group 
Rats of this group received the single intramuscular injection of the 
citrate buffer (1 ml/kg body weight) and this group was subjected to 
oral administration of 1 ml distilled water /kg body weight/day for 
35 days at a gap of 7 days after citrate buffer injection. 
Diabetic group 
Rats were made diabetic by a single intramuscular injection of STZ 
at a dose of 40 mg/kg body weight in citrate buffer. After 7 days of 
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STZ injection, distilled water was administered orally for 35 days to 
diabetic rat at a dose of 1 ml/kg body weight per day after 7 days of 
STZ injection. 
Ethyl acetate fraction treated diabetic group 
After 7 days of STZ injection, diabetic rats of this group were treated with 
ethyl acetate fraction of seed of E. jambolana at the dose of 200 mg/2 ml 
distilled water/kg of body weight/day for 35 days at fasting state. 
Glibenclamide treated diabetic group 
After 7 days of STZ injection, diabetic rats of this group were treated 
with glibenclamide at the dose of 20 mg/kg body weight/day for 35 
days.  
Single dose of ethyl acetate fraction was administered every day 
orally at morning (10.00 a. m.) Using intragastric tube for 35 days. 
Blood glucose levels were estimated in short and long duration 
models. On 36th day of extract treatment (42nd
Animals were sacrificed and hepatic tissue was dissected out from 
the animals and the tissue was immediately allowed to freeze in 
liquid nitrogen. Then the frozen tissue was pulverized and re 
suspended in lysis buffer (Roche Diagnostics, Mannheim, Germany), 
RNA was extracted according to the manufacturers protocol. 
Residual DNA was removed by treatment with 5 units of DNase I 
(Roche Diagnostics, Mannheim, Germany) for 45 min at 37°C 
followed by inactivation for 10 min at 65°C. Then 2 µg of RNA was 
reversed transcribed with Superscript II reverse transcriptase. The 
cDNA was diluted five-fold prior to PCR amplification.  
 day of STZ-injection) 
all animals were sacrificed by cervical decapitation. For the 
measurement of serum insulin level, blood was collected from each 
rat and serum was separated by centrifugation at 3000 rpm for 10 
min. For ISEL study and mRNA expressions of Hex -I, Bax and Bcl-2 
genes, pancreas and liver were dissected out from each animal.  
Screening of antihyperglycemic activity 
Short-duration experimental model 
Blood samples were obtained from the tail vein and FBG levels were 
estimated using a glucometer (Bayer’s Ascensia Entrust, Bayer, 
Germany), after 1, 3, 5, 8 and 24 hours following oral administration 
of a single dose (200 mg/2 ml distilled water/kg of body weight/rat) 
of ethyl acetate fraction or glibenclamide sample to rats.  
Long-duration experimental model  
The levels of FBG in all experimental rats were measured using a 
glucometer (Bayer’s Ascensia Entrust, Bayer, Germany) at the end of 
1, 2, 3, 4 and 5 weeks of treatments using blood samples which have 
been obtained from tail vein. 
Assessment of glycated hemoglobin level  
Glycated hemoglobin level was measured as per standard protocol [16].  
Quantification of serum insulin level 
The level of serum insulin was measured by enzyme- linked 
immunosorbent assay (ELISA) kit for rat (Boehringer Mannheim 
Diagnostic, Mannheim, Germany). Level of insulin was expressed in 
µ IU/ml. 
ISEL study 
ISEL histochemistry of pancreatic tissue was performed using TACS 
TdT-DAB in situ apoptosis detection kit (Trevigen Inc., Gaithersburg, 
MD, U. S. A.) [17].  
RNA extraction and cDNA synthesis 
Real-time quantitative PCR 
Real-time PCR was performed in the Light Cycler 480 (Roche 
Diagnostics, Mannheim, Germany) using the SYBR Green I Master 
mix (Roche Diagnostics). Final mixture of PCR (final volume 20 µl) 
contained 10 µl SYBR Green I mix, 5 µl of cDNA (1:5 dilution) and 0.5 
µM of each primer and 4 µl PCR grade distilled water. PCR 
amplification was initiated with a 10-min pre incubation step at 
95°C, followed by a 35 cycles of denaturation at 95°C for 10 s, 
annealing as described in table 2 and elongation at 72°C for 10 s. 
After amplification, the melting curves were determined in a three-
segment cycle of 95°C for 5 s, 65°C for 15 s and 97°C for 0 s. All PCR 
reactions were performed in triplicates. Primer specificity was 
assessed through melting curve analysis. Primers (rat specific) were 
designed for the gene of interest, i. e. Hex-I, Bax, Bcl-2, and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as reference, 
the sequences of which are detailed in table 1 [18]. 
Statistical analysis 
All data were presented as mean ± SEM, for six rats in each group. 
Comparison between groups or between time points was made by 
one-way analysis of variance (ANOVA) followed by Multiple 
Comparison two-tail ‘t’-test to analyze the significance study. 
Differences were considered significant when p-values were less 
than 0.05 (p<0.05). All statistical analysis were performed using 
SPSS (SPSS Inc, Chicago, USA). 
RESULTS 
Acute effect of ethyl acetate fraction on FBG levels 
Table-2, showed the antihyperglycemic activity of ethyl acetate 
fraction of seed of E. jambolana at different time intervals after 
single dose of oral administration of plant fraction or standard drug, 
glibenclamide. FBG levels were decreased gradually from 3h to 8h 
after administration with ethyl acetate fraction or glibenclamide, but 
thereafter an elevation in FBG levels were noted upto 24th
A significant elevation was noted on FBG levels in STZ-induced 
diabetic rats in compare to the control group. Significant recovery of 
FBG level was noted in fraction treated group in respect to untreated 
diabetic group. After daily administration of ethyl acetate fraction or 
standard drug glibenclamide, at the end of 2, 3, 4 and 5 weeks, the 
percentage of recovery of FBG levels were noted at 27%, 57%, 70% 
and 73% respectively, when compared to the untreated diabetic 
group (p<0.05). But in case of glibenclamide treated group the 
percentage of recovery were noted at 26%, 59%, 72% and 74% in 
respect to untreated diabetic group (p<0.05) (Table 3). 
 hour. The 
most reduction of FBG level was noted in treated groups at 8h. The 
percentage of recovery in fraction treated group was 31%, where 
glibenclamide treated group showed 35% recovery in FBG levels at 
8h, when compared with initial time (p<0.05) of treatment. On the 
other hand, when comparison was made with diabetic group the 
percentage of recovery of blood glucose level at 8h was 37% in 
fraction treated group and 38% in glibenclamide treated group. 
Chronic effect of ethyl acetate fraction on FBG levels 
 
Table 1: Primer-sequence and specific conditions used for PCR amplification of candidate genes 
Gene Primer Sequence Annealing temperature (0 No. of Cycles C) Amplification size (bp) 
Hex-I S 5'-GACCAAGTCAAAAAGATTGA-3' 
AS 5'-TCTTCTCGTGGTTCACCTGC-3' 
62 35 256 
Bax  
 
S 5'-AGACAGGGGCCTTTTTGTTAC-3'  
AS 5'-GAGGACTCCAGCCACAAAGAT-3' 
58 35 482 
Bcl-2 S 5'-CCGGGAGAACAGGGTATGAT-3' 
AS 5'-CAGGTATGCACCCAGAGTGA-3' 
60 35 689 
GAPDH S 5'-ACCACAGTCCATGCCATCAC-3' 
AS 5'-TCCACCACCCTGTTGCTGTA-3' 
58 35 452 
GAPDH-glyceraldehyde 3-phosphate dehydrogenase, S- Sense, AS- Antisense, bp- base pair 
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Table 2: Acute effect of ethyl acetate fraction of seed of E. jambolana on FBG levels in STZ-induced diabetic rat. 
 
Groups 
FBG level (mg/dL) 
Time (h) after a single dose of fraction administration 
 0                                     1                                    3                                     5                                 8                                24 
Control 69.2 ± 2.3 72 ± 3.5 74.4 ± 3.3 71.2 ± 6.4 64.8 ± 2.8 75.2 ± 4.5 
Diabetic 334.8 ± 6.3 335 ± 8.6* 345.2± 7.1* 340.2 ± 3.9* 333.8± 6.9* 346.0 ± 9.9* 
Diabetic +Fraction treated 
* 
315.4 ± 13.8 286.8 ± 8.5** 267.0 ± 6.9** 242.4 ± 9.1** 211.6± 7.76** 248.6± 9.3** 
Diabetic+ Glibenclamide treated 
** 
318.7± 10.2 279.2 ± 7** 258.1 ± 8.3*** 226.5± 7.8*** 208.4± 7*** 252.8± 7.8*** ** 
Data expressed as Mean ± SEM, (n = 6), ANOVA followed by multiple comparisons two tail ‘t’ test. Values with different stars as superscripts (*, **, 
***) in each column differ from each other significantly, p <0.05. 
 
Table 3: Chronic effect of ethyl acetate fraction on FBG levels in control and different experimental groups. 
Groups FBG level (mg / dL) 
1st 8 day th 15 day th 22 day nd 29 day th 35 day th
Control 
 day 
84.83±4.8 86.83±3.3 81.83±4.7 80.5±4.1 86.32±4.7 88.32±4.1 
Diabetic 88.66±4.7 347.6±8.2 353.33±4.1* 345.83±4.2* 341.33±4.6* 346.87±8.2* 
Diabetic +Fraction Treated 
* 
84.16±6.5 345.33±6.4 246.0±4.6* 142.81±4.9** 118.11±3.6** 102.0±3.8** 
Glibenclamide treated 
** 
86.66±4.6 340.66±5.0 241.5±3.6* 132.33±3.2** 98.8±4.1*** 89.97±4.9*** *** 
Data expressed as Mean ± SEM, (n = 6), ANOVA followed by multiple comparison two tail ‘t’ test. Values with different stars as superscripts (*, **, 
***) in each column differ from each other significantly, p <0.05. 
 
Levels of Glycated hemoglobin 
Glycated hemoglobin (HbA1
Effect on serum insulin 
C) level was increased significantly in 
diabetic group in compare to the control group. After treatment with 
ethyl acetate fraction of seed of E. jambolana or glibenclamide, the 
level of glycated hemoglobin was resettled towards the control 
group. Glycated hemoglobin level was insignificantly differ in 
between fraction treated and glibenclamide treated groups (Fig 1). 
Serum insulin level was decreased in the diabetic group in respect to 
the control group. After administration of ethyl acetate fraction to the 
diabetic rats for 35days, serum level of this hormone was signi ficantly 
restored towards the control level. No significant difference of this 
parameter was observed in between the fraction-administered and 
glibenclamide treated groups at 42days of experiment (Fig 1).  
 
 
Fig. 1: Protective efficacy of ethyl acetate fraction or glibenclamide on serum insulin and glycated hemoglobin levels in streptozotocin-
induced diabetic rat. Each bar represents Mean ± SEM, n=6. ANOVA followed by “Multiple Comparison two tail ‘t’ test”. Values of bar 
diagram with different stars (*, **, ***) differ from each other significantly at the level of p<0.05. 
 
ISEL study of pancreas 
Figure-2, shows that very few apoptotic cells were present in control 
group. The ISEL-positive or apoptotic cells in pancreatic islets were 
noted by brown colour in the tissue section (Fig 2). Moreover, 
qualitative analysis revealed more apoptotic cells in pancreatic 
tissue section in diabetic group compared with control group. After 
administration of fraction to the diabetic rats, count of ISEL-positive 
cells in the pancreas was remarkably decreased in compare to the 
untreated diabetic group (Fig 2). 
Effect of ethyl acetate fraction of seed of E. jambolana on hepatic 
Hex-I gene expression 
Down ward expression pattern of the hepatic Hex-I gene in diabetic 
group was noted by qRT-PCR analysis when compared with the 
expression pattern for the same in the control group. A significant 
remedial activity of ethyl acetate fraction or glibenclamide was 
noticed in the said gene expression in target tissue after treatment to 
diabetic group (Fig 3). 
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Fig. 2: Immunohistochemistry of Pancreas; ISEL Study, X 400 indicates apoptotic cells. (A) Representative microphotograph of pancreatic 
section showing normal density of islet cells and very few apoptotic cells in islet present in the control group identified by ISEL study. (B) 
Microphotograph of pancreatic section showing increase in the number of apoptotic cells in islet present in diabetic rat by ISEL study. (C) 
Representative microphotograph of pancreatic section from ethyl acetate fraction treated diabetic rat showing low number of apoptotic 
cell in islet identified by ISEL study in compare to diabetic group. (D) Microphotograph of pancreatic section from glibenclamide treated 
diabetic rat with low count in apoptotic cells in islet in respect to diabetic group. 
 
 
Fig. 3: Representative qRT-PCR analysis of hepatic Hex-I gene expression in rat after normalizing the result with a housekeeping gene, 
GAPDH. Data represents mean ± SEM, n=6. ANOVA followed by “Multiple comparison two tail ‘t’ test”. Different stars (*, **, ***) differ from 
each other significantly at the level of p<0.05 
 
 
Fig. 4: Representative qRT-PCR analysis of hepatic Bax gene expression in rat after normalizing the result with housekeeping gene, 
GAPDH. Data represents Mean ± SEM, n=6. ANOVA followed by “Multiple Comparison two tail ‘t’ test”. Different stars (*, **, ***) differ from 
each other significantly at the level of p<0.05 
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Fig. 5: Representative qRT-PCR analysis of hepatic Bcl-2 gene expression in rat after normalizing the result with housekeeping gene, 
GAPDH. Data represents mean ± SEM, n=6. ANOVA followed by “Multiple Comparison two tail ‘t’ test”. Different stars (*, **, ***) differ from 
each other significantly at the level of p<0.05 
 
Expression of Bax, Bcl-2 genes in hepatic tissue at mRNA level  
Pro-apoptotic marker, Bax was increased and anti-apoptotic marker 
Bcl-2, was decreased significantly (p < 0.05) in hepatic tissue in 
diabetic group with respect to the control group by qRT-PCR 
analysis. After the treatment of said fraction to diabetic rat for 35 
days, a significant recovery (p < 0.05) was observed in the 
expression pattern of hepatic Bax and Bcl-2 genes towards the 
control group (Fig 4, 5). 
DISCUSSION 
The preamble of chemical induced type-1 diabetes mellitus in 
experimental rat is executed using streptozotocin that selectively 
destroys pancreatic β-cells is very convenient and simple to use [19]. 
Streptozotocin causes a massive degeneration of β-cells of the islets 
of Langerhans and induces hyperglycemia through several processes 
such as oxidation of essential-SH groups [20], inhibition in 
glucokinase, disturbances in intracellular calcium homeostasis or 
generation of free radicals [21]. The antihyperglycemic activity of 
ethyl acetate fraction of seed of E. jambolana has been reported 
previously by us [11-14], but it’s molecular mechanism has not yet 
been described clearly.  
In this study, we found that the antihyperglycemic potency of the 
ethyl acetate fraction of E. jambolana in both short and long duration 
models may be due to high solubility of bioactive phytomolecules i. e. 
gallic acid and polyphenolic compounds present of this solvent 
fraction which has been published in our previous publication [12-13, 
22]. The administration of this fraction at a dose level of 200 mg/Kg of 
body weight of rat for single time attenuates FBG level effectively up to 
8 hr may be due to stimulation of pancreatic β–cells for short duration 
insulin release against high blood glucose level by this fraction same as 
activity produced by other synthetic oral drugs like glibenclamide 
which is responsible to increase in sensitization and stimulation of β-
cells against blood glucose [23-24]. The duration of antihyperglycemic 
effect was up to 8 hrs, which may be due to the molecular instability or 
rapid plasma clearance of phytomolecule. 
In long term model, the ethyl acetate fraction treatment for 35 days 
exhibited a significant reduction in the FBG levels towards control 
demonstrated antihyperglycemic property of this herbal fraction. It 
was also supported here by the significant recovery in serum insulin 
level. These effects may be due to the increased release of insulin from 
remaining β-cells and/or regeneration of β-cells [25, 14], and 
restoration of insulin sensitivity [26]. This insulinotropic activity was 
further supported from the low level of glycated hemoglobin due to 
lowering of FBG level [27], as this is under the action of insulin [28].  
The physiological role of hexokinase, the insulin dependent key 
carbohydrate metabolic enzyme of glycolysis has been well studied 
by others [29-30], along with us [15]. The expression pattern of Hex-
1 in total hepatic lysate of all the groups was studied through qRT-
PCR techniques, which revealed the diminished expression of Hex-1 
in diabetic condition in respect to the control. After 35 days of 
chronic treatment, expression pattern of Hex-1 was significantly 
improved in the diabetic rat indicated the recovery in homeostasis of 
carbohydrate similar with the previous findings of other [31], along 
with us [13], which supported the hypothesis that higher level of 
Hex-1 activity reflect a higher rate of glucose utilization by cells [29].  
The Bax gene expression (pro-apoptotic gene) was significantly 
increased along with the diminution in the expression of anti-
apoptotic gene i. e. Bcl-2 in STZ induced diabetic animals which is 
reported previously in this line [32]. So, the level of serum insulin is 
significantly reduced due to destruction of pancreatic β cell under 
the STZ toxicity. Moreover, the expression pattern of hepatic Hex-I 
was significantly decreased in STZ induced diabetic animals as 
insulin is the positive factor in this concern [29]. After the treatment 
of said fraction to diabetic animals the Bax, Bcl-2 and Hex-I gene 
expression pattern was significantly recovered towards the control 
level. From these results it may be predicted that the 
phytomolecules present in this fraction which elevate the serum 
insulin through the resists of pancreatic β cell by the regulation of 
gene expression of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) 
markers [32].  
The loss of β-cells from the endocrine pancreas due to STZ-induced 
free radicals mediated apoptosis, as shown by an increase level of 
ISEL positive cells, and produces the hyperglycaemic state [33]. This 
circumstances enhances excess free radicals generation either by 
auto oxidation of glucose or enzymatic and non-enzymatic glycation 
of proteins with increased formation of glucose derived advanced 
glycosylation end products (AGEs), enhanced glucose flux through 
polyol pathway [34], and reduction of anti-oxidant defence. The 
apoptosis-induced reduction in the beta-cell volume of the pancreas 
also provide an explanation for the decrease of glucose tolerance in 
hyperglycemia and the development diabetes mellitus, which can be 
controlled by this fraction treatment following inhibition in 
absorption of dietary carbohydrates through small intestine. But 
after the treatment of the ethyl acetate fraction or glibenclamide to 
the diabetic rat, degeneration of DNA of pancreatic β-cells was 
inhibited which revealed from decreased ISEL positive cells in 
immunohistological study. The positive regulation in expression 
pattern of Hex-I gene and inhibition in the breakdown of DNA 
towards control established its potency against diabetes may be due 
to its phytoingredients viz. gallic acid compounds present in it as 
they have major antioxidative activity with redox properties [13]. 
CONCLUSION 
The present study demonstrated that the ethyl acetate fraction of 
seed of E. jambolana have a strong antidiabetic activity on 
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experimental model rat at genetic level. So, this study focuses 
promising evidence to the pharmaceutical industry for the 
development of drug by this fraction for the correction of different 
complications of diabetes. 
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